Florfenicol 570, Down Over 8%, Tilmicosin Down Over 4%...
Entering the new year, various varieties of veterinary drug raw materials have continued to decline. Among the veterinary drug raw materials monitored by the China Veterinary Drug and Feed Trading Center, florfenicol has led the decline.
On the 5th, the average price of florfenicol was 570 yuan/kg, down 8.80% from the previous month. After four months, the price returned to below 600.
In addition to florfenicol, the prices of tiamulin, doxycycline hydrochloride and other products have also declined to varying degrees.
On the whole, after New Year's Day, the veterinary drug API market continued to operate weakly, with light trading, lack of market confidence, and average transactions.
The epidemic is superimposed on stocking before the festival, and history repeats itself?
Entering the twelfth lunar month, there is a demand for pre-holiday stocking downstream, which may drive the overall downstream demand for veterinary APIs and boost market confidence.
At the same time, it is necessary to pay special attention to the recent domestic epidemic situation, especially the epidemic situation in Henan and other places where veterinary raw materials are produced, and replenish and adjust the goods in time to prevent the recurrence of the situation in early 2021.
At the beginning of 2021, the epidemic situation in Hebei, an important production area of veterinary drug raw materials, was repeated and entered a wartime state. Due to the needs of epidemic prevention and control, many expressways in Hebei were prohibited from going on the road and persuaded to return vehicles. The abnormal logistics has resulted in the lack of an important part of the normal supply of veterinary drug raw materials, the imbalance of supply and demand, and the shortage of stock has become the current norm. The epidemic situation superimposed the pre-holiday stocking, and the price of veterinary drug raw materials rose in response.
At the same time point, the same event, the pre-holiday stockpiling superimposed on the epidemic prevention and control of the main producing areas of veterinary drug raw materials, and whether the operation of the veterinary drug raw materials market will repeat history, we may wish to wait and see.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
February Market Analysis of Raw Materials for Veterinary Medicines
-
The Average Prices of Tylosin Tartrate And Tilmicosin Dropped by 12.33% And 10.31% From Their Highs During The Year
-
Market analysis of veterinary drug feed ingredients
-
The peak season is approaching, the veterinary raw material drug market may rebound!
-
The price of veterinary raw materials has jumped, what is the reason?
-
Market Analysis - Monthly Report - August, 2020 - Florfenicol
-
Market Analysis - Monthly Report - June, 2020 - Florfenicol
-
Market Analysis - Monthly Report - May, 2020 - Florfenicol
-
Market Analysis - Monthly Report - May, 2020 -Tilmicosin Phosphate
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
Recommend Reading
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Novo Nordisk Reports Theft of Six Drug Batches in India Authorities Warn of Severe Patient Safety Risks
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Wanhua Gaoxin Net Profit Surges 97 Percent in H1 2025 Launches 10 Billion Yuan PVA Resin Project
-
CP Chem Doubles PAO Capacity in Belgium to 120000 Tons Now Europe’s Largest Low-Viscosity Base Oil Facility
-
China Unveils Battery Breakthrough with 600Wh/kg Cell Flight Endurance Boosted 2.8 Times
-
Major Leadership Changes at Sinopec New General Managers Appointed at Zhongyuan and Exploration Divisions
-
China National Chemical Engineering Signs 206.1 Billion Yuan in H1 2025 Contracts Top 10 Projects Surpass 290 Billion